High Tech Pharm Co., Ltd. (KOSDAQ:106190)

South Korea flag South Korea · Delayed Price · Currency is KRW
19,530
-920 (-4.50%)
At close: Apr 9, 2026
Market Cap207.03B +23.8%
Revenue (ttm)70.18B -9.5%
Net Income11.48B -16.3%
EPSn/a
Shares Out10.63M
PE Ratio18.04
Forward PEn/a
Dividend150.00 (0.77%)
Ex-Dividend DateDec 29, 2025
Volume81,503
Average Volume180,913
Open20,400
Previous Close20,450
Day's Range18,840 - 20,400
52-Week Range10,700 - 25,000
Beta0.19
RSI53.03
Earnings DateApr 15, 2026

About High Tech Pharm

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1998
Employees 65
Stock Exchange KOSDAQ
Ticker Symbol 106190
Full Company Profile

Financial Performance

In 2025, High Tech Pharm's revenue was 70.18 billion, a decrease of -9.46% compared to the previous year's 77.51 billion. Earnings were 11.48 billion, a decrease of -16.30%.

Financial Statements